Stay updated on Modakafusp Alfa + Daratumumab in MM Clinical Trial
Sign up to get notified when there's something new on the Modakafusp Alfa + Daratumumab in MM Clinical Trial page.

Latest updates to the Modakafusp Alfa + Daratumumab in MM Clinical Trial page
- Check4 days agoChange DetectedThe page updates to Revision: v3.0.2 (replacing v3.0.1), and the Back to Top link is removed.SummaryDifference0.6%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.6%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. This indicates a shift towards a more streamlined presentation of location information.SummaryDifference26%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check39 days agoChange DetectedThe study has been terminated early after the sponsor decided not to proceed with Phase 2a, and no participants were enrolled for this phase.SummaryDifference7%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to Modakafusp Alfa + Daratumumab in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Modakafusp Alfa + Daratumumab in MM Clinical Trial page.